15 reports

China’s demand for Cardiovascular Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...

  • Cardiovascular Drug
  • China
  • Industrial Production
  • Labour Force

Major companies in the market include Medtronic Inc., Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences, Cardinal Health, Inc., Johnson & Johnson, Terumo Corporation, Getinge Group, Teleflex Inc. and Becton Dickinson. The global cardiovascular drugs market is expected to grow from $146.51 billion in 2021 to $153.60...

  • Cardiovascular Drug
  • Cardiovascular Disease
  • World
  • Chronic Disease Prevalence
  • Labour Utilisation

INTRODUCTION Cardiovascular diseases (CVD) are reported to be one of the leading causes of deaths across the globe, surpassing conditions, such as cancer and respiratory disorders. According to the WHO, around one third of the annual global deaths (an estimated 18 million) can be attributed to cardiac disorders. Specifically,...

  • Cardiovascular Drug
  • World
  • Europe
  • North America
  • Latin America
  • Asia
  • MENA

The Cardiovascular drug market studied was anticipated to grow with a CAGR of nearly 3.8% during the forecast period. The major factors driving the growth of the market are the rising global prevalence of various coronary heart diseases such as stroke, cardiomyopathy causing a global burden of cardiac deaths and favorable reimbursement initiatives....

  • Cardiovascular Disease
  • Cardiovascular Drug
  • In-Store Retail
  • World
  • Europe
  • North America
  • APAC
  • South America
  • Middle East
  • Cause-Specific Mortality Rate
  • Elderly Population

Major companies in the cardiovascular drugs market include Merck & Co; Sanofi S.A; Pfizer Inc; Bristol-Myers Squibb Company and Novartis AG. The global cardiovascular drugs market is expected to grow from $87.79 billion in 2020 to $92.41 billion in 2021 at a compound annual growth rate (CAGR) of 5.3%. The growth is mainly due to the...

  • Cardiovascular Drug
  • World
  • Chronic Disease Prevalence
  • Labour Utilisation

Abstract: - Global Cardiovascular Drugs Market to Reach $80 Billion by 2027 - Amid the COVID-19 crisis, the global market for Cardiovascular Drugs estimated at US$79.8 Billion in the year 2020, is projected to reach a revised size of US$80 Billion by 2027, growing at a CAGR of 0% over the analysis period 2020-2027....

  • Cardiovascular Drug
  • World
  • China
  • United States

This study focuses on China’s Cardiovascular Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China...

  • Cardiovascular Drug
  • China
  • Employment Costs
  • Pharmaceutical Production

This study focuses on China’s Cardiovascular Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s...

  • Cardiovascular Drug
  • China
  • Industrial Production
  • Labour Force

Empty Capsules Market Size, Outlook and Growth Opportunities, 2019- 2025 Global Empty Capsules Market Size, Outlook and Growth Opportunities to 2025: By Type (Gelatin Capsules, Non-Gelatin Capsules), By Functionality (Immediate-Release Capsules, Sustained-Release Capsules, and Delayed-Release Capsules), By Application...

  • Pharmaceutical
  • Healthcare
  • Anti-Infective
  • Cardiovascular Drug
  • Cough And Cold
  • Nutraceutical
  • Gelatin
  • Dietary Supplement
  • Analgesic
  • Cosmetics
  • World
  • APAC
  • Asia
  • Europe
  • North America
  • Middle East
  • Africa
  • Latin America
  • Health Expenditure

Report Scope: This report provides detailed exposure of the cardiovascular drugs market, highlighting major cardiovascular diseases with detailed epidemiology for the primary disease areas. The report includes an industrywide assessment of the novel product launches, recent approvals, research and development pipeline,...

  • Cardiovascular Drug
  • World

Global Cardiovascular Drugs Market: Overview Cardiovascular drugs are widely used for treating various heart related dysfunction.With increasing number of cardiovascular diseases across the globe is the major driving factor for the growth of the cardiovascular diseases. According to the study conducted by Global...

  • Cardiovascular Drug
  • World
  • Young Population

Cardiovascular drugs market covers the drugs used to treat conditions that affect the heart or blood vessels. These conditions include heart stroke, coronary artery diseases, valvular diseases, peripheral venous diseases, pericarditis, endocarditis, cardiac tumors, arteriosclerosis, and lymphatic diseases. Some of the major cardiovascular...

  • Cardiovascular Drug
  • World
  • Health Expenditure
  • Drug Approval

Cardiovascular Disorders Drug Development Pipeline Review, 2017 Summary Cardiovascular disease (CVD) covers a range of difference diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD are hypertension and dyslipidemia of which accelerate the development of atherosclerotic...

  • Cholesterol
  • Pharmaceutical
  • Heart Failure
  • Hypertension
  • Antihypertensive
  • Statins

Summary Guangxi Wuzhou Zhongheng Group Co Ltd (GWZG) is a pharmaceutical company that provides cardiovascular drugs. The company offers products which include cardiovascular drugs, gynecological treatment, qingrexiaoyan medication, urology treatment, bruises branch medications, pediatric medication, oncology drugs, diagnostic agents...

  • Pharmaceutical
  • Cardiovascular Drug
  • China
  • APAC
  • Europe
  • North America
  • Middle East
  • Africa
  • Central America

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Coronary artery disease (CAD), which precipitates acute coronary syndrome (ACS), is the most common type of cardiovascular disease (CVD) in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)....

  • Hospital
  • Therapy
  • Statins
  • Cardiovascular Drug
  • Acute Coronary Syndrome
  • ACE Inhibitor
  • World
  • Hospital Occupancy Rate
  • Infectious Disease Mortality